Skip to content
Qvin logo — Empowering women. Period.

Qvin

Empowering women. Period.

Founded 2014 United States Menlo Park, United States 16 employees Venture round Total: $12.27M Health Care, Medical Devices

General Information

Company Name Qvin
Founded Year 2014
Location United States Menlo Park, United States
Employees 16
Industries Health Care, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Qvin. To contact Qvin, visit qvin.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Qvin compare?

A PDF of Qvin and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Qvin soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Qvin

Qvin is a health care startup that aims to empower women by offering a pioneering solution for managing their health. Founded in 2014 and based in the United States, Qvin's slogan "Empowering women. Period." resonates with its focus on leveraging menstrual blood as a health testing source. Their vision is to provide individuals who menstruate with the opportunity to proactively and routinely manage their health using menstrual blood. In March 2021, the company secured a significant $12.27M Venture Round investment. This demonstrates the confidence of investors in Qvin's innovative approach and the potential impact it could have in the health care industry. With its unique value proposition and recent investment, Qvin is poised for continued growth and advancement in the field of women's health and wellness.

Business keywords: women's health, menstrual blood testing, non-invasive testing, health empowerment, preventive healthcare, data-driven healthcare, female empowerment, personal health monitoring

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $12.27M -
01 Mar 2021
Series A Undisclosed 1
SandHill Angels
25 Sep 2020
Seed Round Undisclosed 9
Two Sigma Ventures, AltaIR Capital +7
05 Sep 2018
Seed Round Undisclosed -
22 Mar 2016

Qvin Alternatives & Competitors

View All Alternatives
Qvin vs
Toku
Toku United States

Window to your Future Health

Series A
21 employees
Health Care, Medical Devices
Qvin vs
Elitone by Elidah
Elitone by Elidah United States

We empower women to be boss of their bladders.

Series A
7 employees
Health Care, Health and Wellness
Qvin vs
Ava Women
Ava Women Switzerland

Advancing women’s reproductive health by bringing together artificial intelligence and clinical res...

Series B
6 employees
Health Care, Health and Wellness

FAQ About Qvin

Empowering women. Period.
Qvin was founded in 2014.
Qvin is headquartered in Menlo Park, United States.
Qvin operates in Health Care and Medical Devices. Its work centres on women's health, menstrual blood testing, non-invasive testing and health empowerment.
Qvin has approximately 16 employees.
Qvin has completed 4 funding rounds, raising a total of $12.27M. The latest funding stage is Venture round.
Top alternatives and competitors to Qvin include Toku, Elitone by Elidah, Ava Women , Sight Diagnostics, SunTech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Qvin and Toku are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Qvin, https://www.bouncewatch.com/company/qvin, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout